| Home : Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in Diffuse Large B Cell Lymphoma |
|
Dec 01
2020 |
Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in Diffuse Large B Cell Lymphoma |
|
OSLO, Norway, Dec. 1, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it has completed enrolment into the LYMRIT 37-05 Phase 1 clinical trial of Betalutin® (177Lu lilotomab satetraxetan) in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/nordic-nanovector-completes-patient-enrolment-into-phase-1-trial-of-betalutin-in-diffuse-large-b-cell-lymphoma-301182172.html |
| |
|
Related News
|
» Artist Anjalts To Finish Art And Poetry Book About Gaia - Spirit Of The Earth
» Dreame представляет беспроводной пылесос T20 и робот-пылесос D9 на AliExpress
|
